| ISIN | CH0467052848 |
|---|---|
| Valor Number | 46705284 |
| Bloomberg Global ID | AXASWES SW |
| Fund Name | AXA (CH) Strategy Fund - Swiss Equity CHF S Distribution Yearly CHF |
| Fund Provider |
AXA Leben AG
Phone: +41 0800 809 809 Web: https://www.axa-winterthur.ch |
| Fund Provider | AXA Leben AG |
| Representative in Switzerland | |
| Distributor(s) |
AXA Leben AG Winterthur |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of this subfund is to generate growth in value and an appropriate return in CHF from an actively managed portfolio of Swiss equities. The fund management company strives to achieve an equity market exposure of at least 90% in the Swiss Equity CHF. |
| Peculiarities |
| Current Price * | 146.05 CHF | 16.01.2026 |
|---|---|---|
| Previous Price * | 146.11 CHF | 15.01.2026 |
| 52 Week High * | 146.11 CHF | 15.01.2026 |
| 52 Week Low * | 119.86 CHF | 09.04.2025 |
| NAV * | 146.05 CHF | 16.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 323,692,557 | |
| Unit/Share Assets *** | 323,692,557 | |
| Trading Information SIX | ||
| YTD Performance | +3.87% |
30.12.2025 - 16.01.2026
30.12.2025 16.01.2026 |
|---|---|---|
| 1 month | +5.89% |
16.12.2025 - 16.01.2026
16.12.2025 16.01.2026 |
| 3 months | +6.96% |
16.10.2025 - 16.01.2026
16.10.2025 16.01.2026 |
| 6 months | +5.78% |
16.07.2025 - 16.01.2026
16.07.2025 16.01.2026 |
| 1 year | +8.98% |
16.01.2025 - 16.01.2026
16.01.2025 16.01.2026 |
| 2 years | +21.22% |
16.01.2024 - 16.01.2026
16.01.2024 16.01.2026 |
| 3 years | +19.05% |
16.01.2023 - 16.01.2026
16.01.2023 16.01.2026 |
| 5 years | +24.86% |
18.01.2021 - 16.01.2026
18.01.2021 16.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 8.66% | |
|---|---|---|
| Nestle SA | 7.64% | |
| Julius Baer Gruppe AG | 5.19% | |
| Novartis AG Registered Shares | 5.03% | |
| VAT Group AG | 4.35% | |
| Lonza Group Ltd | 4.32% | |
| UBS Group AG Registered Shares | 4.25% | |
| PSP Swiss Property AG | 4.16% | |
| SGS AG | 3.64% | |
| Chocoladefabriken Lindt & Spruengli AG Ordinary Shares - Non Voting | 3.62% | |
| Last data update | 31.12.2025 | |
| TER | 0.37% |
|---|---|
| TER date | 30.09.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.70% |
| Ongoing Charges *** | 0.38% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |